Physician profile
Jane Kim
NPI 1396265807
$1,229.92
in general payments reported to CMS, 2019-2025
15 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $135 · 2022: $458 · 2023: $87.34 · 2024: $408 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $398.24 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $145.38 | 2024 | |
| Boston Scientific Corporation | $126.04 | 2023-2025 | Watchman Flx |
| Nestle Healthcare Nutrition INC. | $120.40 | 2022 | |
| Ferring Pharmaceuticals INC. | $74.41 | 2021-2022 | |
| Janssen Biotech, INC. | $53.43 | 2023-2025 | Tremfya, Remicade, Stelara |
| Medtronic, INC. | $52.95 | 2024 | Mycarelink |
| Takeda Pharmaceuticals U.S.A., INC. | $50.41 | 2024-2025 | Livtencity, Eohilia |
| Amgen INC. | $44.48 | 2023 | Blincyto, Kyprolis |
| Daiichi Sankyo INC. | $37.42 | 2024 | Vanflyta |
| Alnylam Pharmaceuticals INC. | $37.00 | 2025 | Amvuttra |
| Jazz Pharmaceuticals INC. | $32.96 | 2024 | |
| Depuy Synthes Sales INC. | $22.68 | 2025 | Trufill |
| Rigel Pharmaceuticals, INC. | $19.69 | 2024 | Rezlidhia, Tavalisse |
| Braintree Laboratories, INC. | $14.43 | 2024 | Suflave, Sutab |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.